Company Profile
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of pulmonary arterial hypertension (PAH).
Contact Information
Investor Relations
LifeSci Advisors
Mike Moyer
Managing Director
T: 617-308-4307
mmoyer@lifesciadvisors.com
Company Contact
Inhibikase Therapeutics, Inc.
3350 Riverwood Parkway
Suite 1900
Atlanta, GA 30339
T: 617-936-0184
info@inhibikase.com